Outcomes of transcatheter device closure in atrial septal defect secundum in Kelantan : a single center experience

dc.contributor.authorNiza@Nizal, Hanif Mohd@Mohd
dc.date.accessioned2020-01-16T07:44:03Z
dc.date.available2020-01-16T07:44:03Z
dc.date.issued2018
dc.description.abstractBackground – To look at demographic, procedural and clinical characteristic of patients with atrial septal defect secundum (ASDs) who underwent transcatheter device closure, median survival time to ASDs closure and its outcome in pediatric and adult patients. Material and methods – This retrospective study was conducted from January 2005 to December 2015 in patients with ASDs underwent transcatheter device closure at Hospital Universiti Sains Malaysia. Results – 73 patients (42 children and 31 adults) with 75% of female predominance. Median age at diagnosis was 8 years old and median age at procedure was 15 years old. 25% of patients are symptomatic on procedural day, with reduced effort tolerance being the most reported symptoms (83%). Majority of patients had large ASDs, with median of 22mm (7mm – 33.6mm), with 60% of patients had rim deficiency. Median survival time of ASDs closure in pediatric and adult age group were 3 years and 2 years respectively. Success rate was 90.4%. There was 5.5% residual shunt immediately after procedure, with 100% complete resolution at the end of follow-up at 2 years. Conclusions – Transcatheter device closure is safe and effective in large ASDs population with rim deficiency, with comparable outcome and minimal serious complication.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/9439
dc.language.isoenen_US
dc.publisherPusat Pengajian Sains Perubatan, Universiti Sains Malaysiaen_US
dc.subjectHeart septal defectsen_US
dc.subjectAtrialen_US
dc.titleOutcomes of transcatheter device closure in atrial septal defect secundum in Kelantan : a single center experienceen_US
dc.typeThesisen_US
Files
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: